Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion.

Abstract

Reduced expression of 2'-3'-cyclic nucleotide 3'-phosphodiesterase (Cnp) in humans and mice causes white matter inflammation and catatonic signs. These consequences are experimentally alleviated by microglia ablation via colony-stimulating factor 1 receptor (CSF1R) inhibition using PLX5622. Here we address for the first time preclinical topics crucial for translation, most importantly 1) the comparison of 2 long-term PLX5622 applications (prevention and treatment) vs. 1 treatment alone, 2) the correlation of catatonic signs and executive dysfunction, 3) the phenotype of leftover microglia evading depletion, and 4) the role of intercellular interactions for efficient CSF1R inhibition. Based on our Cnp-/- mouse model and in vitro time-lapse imaging, we report the unexpected discovery that microglia surviving under PLX5622 display a highly inflammatory phenotype including aggressive premortal phagocytosis of oligodendrocyte precursor cells. Interestingly, ablating microglia in vitro requires mixed glial cultures, whereas cultured pure microglia withstand PLX5622 application. Importantly, 2 extended rounds of CSF1R inhibition are not superior to 1 treatment regarding any readout investigated (magnetic resonance imaging and magnetic resonance spectroscopy, behavior, immunohistochemistry). Catatonia-related executive dysfunction and brain atrophy of Cnp-/- mice fail to improve under PLX5622. To conclude, even though microglia depletion is temporarily beneficial and worth pursuing, complementary treatment strategies are needed for full and lasting recovery.-Fernandez Garcia-Agudo, L., Janova, H., Sendler, L. E., Arinrad, S., Steixner, A. A., Hassouna, I., Balmuth, E., Ronnenberg, A., Schopf, N., van der Flier, F. J., Begemann, M., Martens, H., Weber, M. S., Boretius, S., Nave, K.-A., Ehrenreich, H. Genetically induced brain inflammation by Cnp deletion transiently benefits from microglia depletion.

• Authors: Laura Fernandez Garcia-Agudo, Hana Janova, Lea E Sendler, Sahab Arinrad, Agnes A Steixner, Imam Hassouna, Evan Balmuth, Anja Ronnenberg, Nadine Schopf, Felicia J van der Flier, Martin Begemann, Henrik Martens, Martin S Weber, Susann Boretius, Klaus-Armin Nave, Hannelore Ehrenreich
• Journal: FASEB journal : official publication of the Federation of American Societies for Experimental Biology (FASEB J) Vol. 33 Issue 7 Pg. 8634-8647 (07 2019) ISSN: 1530-6860 [Electronic] United States
• PMID: 31090455 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Organic Chemicals
• PLX5622
• Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
• 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase
• CNP protein, human

Topics

• 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase (genetics)
• Adult
• Animals
• Brain (drug effects, pathology)
• Encephalitis (genetics)
• Female
• Humans
• Male
• Mice
• Mice, Inbred C57BL
• Microglia (drug effects, pathology)
• Organic Chemicals (pharmacology)
• Phenotype
• Receptors, Granulocyte-Macrophage Colony-Stimulating Factor (genetics)
• Sequence Deletion (drug effects, genetics)